Selected research
Market Structure
Global Comparator Drug and Ancillary Materials Sourcing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Comparator Drug and Ancillary Materials Sourcing market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Comparator Drug and Ancillary Materials Sourcing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Comparator Drug and Ancillary Materials Sourcing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Comparator Drug and Ancillary Materials Sourcing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Comparator Drug and Ancillary Materials Sourcing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Comparator Drug and Ancillary Materials Sourcing include Alliance Pharm, Almac Group, Catalent, Cencora, ClientPharma, Clinical Services International (CSI), Clinigen, Globyz Pharma and Inceptua, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Comparator Drug and Ancillary Materials Sourcing market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Comparator Drug and Ancillary Materials Sourcing and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Comparator Drug and Ancillary Materials Sourcing sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Comparator Drug and Ancillary Materials Sourcing market size, projected growth trends, production technologies, key applications, and end-use industries.
Comparator Drug and Ancillary Materials Sourcing Segment by Company
Alliance Pharm
Almac Group
Catalent
Cencora
ClientPharma
Clinical Services International (CSI)
Clinigen
Globyz Pharma
Inceptua
Mckesson Corporation
Myonex
NewLife Medicals
Oximio
Sharp Services, LLC
Wuxi New Drug Development
Thermo Fisher Scientific
Comparator Drug and Ancillary Materials Sourcing Segment by Type
Local Sourcing
Central Sourcing
Others
Comparator Drug and Ancillary Materials Sourcing Segment by Application
Drug Producers/Manufacturers
Academic and Research Institute
CMO
Others
Comparator Drug and Ancillary Materials Sourcing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Comparator Drug and Ancillary Materials Sourcing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Comparator Drug and Ancillary Materials Sourcing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Comparator Drug and Ancillary Materials Sourcing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Comparator Drug and Ancillary Materials Sourcing market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Comparator Drug and Ancillary Materials Sourcing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Comparator Drug and Ancillary Materials Sourcing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Comparator Drug and Ancillary Materials Sourcing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
List of Tables
Table 1. Comparator Drug and Ancillary Materials Sourcing Industry Trends
Table 2. Comparator Drug and Ancillary Materials Sourcing Industry Drivers
Table 3. Comparator Drug and Ancillary Materials Sourcing Industry Opportunities and Challenges
Table 4. Comparator Drug and Ancillary Materials Sourcing Industry Restraints
Table 5. Global Comparator Drug and Ancillary Materials Sourcing Revenue by Manufacturers (US$ Million) & (2021-2026)
Table 6. Global Comparator Drug and Ancillary Materials Sourcing Revenue Market Share by Manufacturers (2021-2026)
Table 7. Global Comparator Drug and Ancillary Materials Sourcing Sales by Manufacturers (k units) & (2021-2026)
Table 8. Global Comparator Drug and Ancillary Materials Sourcing Sales Market Share by Manufacturers
Table 9. Global Comparator Drug and Ancillary Materials Sourcing Average Sales Price (USD/unit) of Manufacturers (2021-2026)
Table 10. Global Comparator Drug and Ancillary Materials Sourcing Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
Table 11. Global Comparator Drug and Ancillary Materials Sourcing Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Comparator Drug and Ancillary Materials Sourcing Manufacturers, Product Type & Application
Table 13. Global Comparator Drug and Ancillary Materials Sourcing Manufacturers Establishment Date
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Comparator Drug and Ancillary Materials Sourcing by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025)
Table 16. Major Manufacturers of Local Sourcing
Table 17. Major Manufacturers of Central Sourcing
Table 18. Major Manufacturers of Others
Table 19. Global Comparator Drug and Ancillary Materials Sourcing Sales by Type 2021 VS 2025 VS 2032 (k units)
Table 20. Global Comparator Drug and Ancillary Materials Sourcing Sales by Type (2021-2026) & (k units)
Table 21. Global Comparator Drug and Ancillary Materials Sourcing Sales by Type (2027-2032) & (k units)
Table 22. Global Comparator Drug and Ancillary Materials Sourcing Sales Market Share by Type (2021-2026)
Table 23. Global Comparator Drug and Ancillary Materials Sourcing Sales Market Share by Type (2027-2032)
Table 24. Global Comparator Drug and Ancillary Materials Sourcing Revenue by Type 2021 VS 2025 VS 2032 (k units)
Table 25. Global Comparator Drug and Ancillary Materials Sourcing Revenue by Type (2021-2026) & (k units)
Table 26. Global Comparator Drug and Ancillary Materials Sourcing Revenue by Type (2027-2032) & (k units)
Table 27. Global Comparator Drug and Ancillary Materials Sourcing Revenue Market Share by Type (2021-2026)
Table 28. Global Comparator Drug and Ancillary Materials Sourcing Revenue Market Share by Type (2027-2032)
Table 29. Major Manufacturers of Drug Producers/Manufacturers
Table 30. Major Manufacturers of Academic and Research Institute
Table 31. Major Manufacturers of CMO
Table 32. Major Manufacturers of Others
Table 33. Global Comparator Drug and Ancillary Materials Sourcing Sales by Application 2021 VS 2025 VS 2032 (k units)
Table 34. Global Comparator Drug and Ancillary Materials Sourcing Sales by Application (2021-2026) & (k units)
Table 35. Global Comparator Drug and Ancillary Materials Sourcing Sales by Application (2027-2032) & (k units)
Table 36. Global Comparator Drug and Ancillary Materials Sourcing Sales Market Share by Application (2021-2026)
Table 37. Global Comparator Drug and Ancillary Materials Sourcing Sales Market Share by Application (2027-2032)
Table 38. Global Comparator Drug and Ancillary Materials Sourcing Revenue by Application 2021 VS 2025 VS 2032 (k units)
Table 39. Global Comparator Drug and Ancillary Materials Sourcing Revenue by Application (2021-2026) & (k units)
Table 40. Global Comparator Drug and Ancillary Materials Sourcing Revenue by Application (2027-2032) & (k units)
Table 41. Global Comparator Drug and Ancillary Materials Sourcing Revenue Market Share by Application (2021-2026)
Table 42. Global Comparator Drug and Ancillary Materials Sourcing Revenue Market Share by Application (2027-2032)
Table 43. Global Comparator Drug and Ancillary Materials Sourcing Sales by Region: 2021 VS 2025 VS 2032 (k units)
Table 44. Global Comparator Drug and Ancillary Materials Sourcing Sales by Region (2021-2026) & (k units)
Table 45. Global Comparator Drug and Ancillary Materials Sourcing Sales Market Share by Region (2021-2026)
Table 46. Global Comparator Drug and Ancillary Materials Sourcing Sales Forecasted by Region (2027-2032) & (k units)
Table 47. Global Comparator Drug and Ancillary Materials Sourcing Sales Forecasted Market Share by Region (2027-2032)
Table 48. North America Comparator Drug and Ancillary Materials Sourcing Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units)
Table 49. North America Comparator Drug and Ancillary Materials Sourcing Sales by Country (2021-2026) & (k units)
Table 50. North America Comparator Drug and Ancillary Materials Sourcing Sales by Country (2027-2032) & (k units)
Table 51. Europe Comparator Drug and Ancillary Materials Sourcing Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units)
Table 52. Europe Comparator Drug and Ancillary Materials Sourcing Sales by Country (2021-2026) & (k units)
Table 53. Europe Comparator Drug and Ancillary Materials Sourcing Sales by Country (2027-2032) & (k units)
Table 54. Asia Pacific Comparator Drug and Ancillary Materials Sourcing Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units)
Table 55. Asia Pacific Comparator Drug and Ancillary Materials Sourcing Sales by Country (2021-2026) & (k units)
Table 56. Asia Pacific Comparator Drug and Ancillary Materials Sourcing Sales by Country (2027-2032) & (k units)
Table 57. South America, Middle East and Africa Comparator Drug and Ancillary Materials Sourcing Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units)
Table 58. South America, Middle East and Africa Comparator Drug and Ancillary Materials Sourcing Sales by Country (2021-2026) & (k units)
Table 59. South America, Middle East and Africa Comparator Drug and Ancillary Materials Sourcing Sales by Country (2027-2032) & (k units)
Table 60. Global Comparator Drug and Ancillary Materials Sourcing Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 61. Global Comparator Drug and Ancillary Materials Sourcing Revenue by Region (2021-2026) & (US$ Million)
Table 62. Global Comparator Drug and Ancillary Materials Sourcing Revenue by Region (2027-2032) & (US$ Million)
Table 63. Global Comparator Drug and Ancillary Materials Sourcing Revenue Market Share by Region (2021-2026)
Table 64. Global Comparator Drug and Ancillary Materials Sourcing Revenue Market Share by Region (2027-2032)
Table 65. Alliance Pharm Company Information
Table 66. Alliance Pharm Business Overview
Table 67. Alliance Pharm Comparator Drug and Ancillary Materials Sourcing Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 68. Alliance Pharm Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 69. Alliance Pharm Recent Development
Table 70. Almac Group Company Information
Table 71. Almac Group Business Overview
Table 72. Almac Group Comparator Drug and Ancillary Materials Sourcing Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 73. Almac Group Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 74. Almac Group Recent Development
Table 75. Catalent Company Information
Table 76. Catalent Business Overview
Table 77. Catalent Comparator Drug and Ancillary Materials Sourcing Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 78. Catalent Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 79. Catalent Recent Development
Table 80. Cencora Company Information
Table 81. Cencora Business Overview
Table 82. Cencora Comparator Drug and Ancillary Materials Sourcing Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 83. Cencora Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 84. Cencora Recent Development
Table 85. ClientPharma Company Information
Table 86. ClientPharma Business Overview
Table 87. ClientPharma Comparator Drug and Ancillary Materials Sourcing Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 88. ClientPharma Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 89. ClientPharma Recent Development
Table 90. Clinical Services International (CSI) Company Information
Table 91. Clinical Services International (CSI) Business Overview
Table 92. Clinical Services International (CSI) Comparator Drug and Ancillary Materials Sourcing Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 93. Clinical Services International (CSI) Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 94. Clinical Services International (CSI) Recent Development
Table 95. Clinigen Company Information
Table 96. Clinigen Business Overview
Table 97. Clinigen Comparator Drug and Ancillary Materials Sourcing Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 98. Clinigen Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 99. Clinigen Recent Development
Table 100. Globyz Pharma Company Information
Table 101. Globyz Pharma Business Overview
Table 102. Globyz Pharma Comparator Drug and Ancillary Materials Sourcing Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 103. Globyz Pharma Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 104. Globyz Pharma Recent Development
Table 105. Inceptua Company Information
Table 106. Inceptua Business Overview
Table 107. Inceptua Comparator Drug and Ancillary Materials Sourcing Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 108. Inceptua Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 109. Inceptua Recent Development
Table 110. Mckesson Corporation Company Information
Table 111. Mckesson Corporation Business Overview
Table 112. Mckesson Corporation Comparator Drug and Ancillary Materials Sourcing Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 113. Mckesson Corporation Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 114. Mckesson Corporation Recent Development
Table 115. Myonex Company Information
Table 116. Myonex Business Overview
Table 117. Myonex Comparator Drug and Ancillary Materials Sourcing Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 118. Myonex Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 119. Myonex Recent Development
Table 120. NewLife Medicals Company Information
Table 121. NewLife Medicals Business Overview
Table 122. NewLife Medicals Comparator Drug and Ancillary Materials Sourcing Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 123. NewLife Medicals Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 124. NewLife Medicals Recent Development
Table 125. Oximio Company Information
Table 126. Oximio Business Overview
Table 127. Oximio Comparator Drug and Ancillary Materials Sourcing Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 128. Oximio Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 129. Oximio Recent Development
Table 130. Sharp Services, LLC Company Information
Table 131. Sharp Services, LLC Business Overview
Table 132. Sharp Services, LLC Comparator Drug and Ancillary Materials Sourcing Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 133. Sharp Services, LLC Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 134. Sharp Services, LLC Recent Development
Table 135. Wuxi New Drug Development Company Information
Table 136. Wuxi New Drug Development Business Overview
Table 137. Wuxi New Drug Development Comparator Drug and Ancillary Materials Sourcing Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 138. Wuxi New Drug Development Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 139. Wuxi New Drug Development Recent Development
Table 140. Thermo Fisher Scientific Company Information
Table 141. Thermo Fisher Scientific Business Overview
Table 142. Thermo Fisher Scientific Comparator Drug and Ancillary Materials Sourcing Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 143. Thermo Fisher Scientific Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 144. Thermo Fisher Scientific Recent Development
Table 145. Key Raw Materials
Table 146. Raw Materials Key Suppliers
Table 147. Comparator Drug and Ancillary Materials Sourcing Distributors List
Table 148. Comparator Drug and Ancillary Materials Sourcing Customers List
Table 149. Research Programs/Design for This Report
Table 150. Authors List of This Report
Table 151. Secondary Sources
Table 152. Primary Sources
List of Figures
Figure 1. Comparator Drug and Ancillary Materials Sourcing Product Image
Figure 2. Global Comparator Drug and Ancillary Materials Sourcing Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Comparator Drug and Ancillary Materials Sourcing Market Size (2021-2032) & (US$ Million)
Figure 4. Global Comparator Drug and Ancillary Materials Sourcing Sales (2021-2032) & (k units)
Figure 5. Global Comparator Drug and Ancillary Materials Sourcing Average Price (USD/unit) & (2021-2032)
Figure 6. Global Top 5 and 10 Comparator Drug and Ancillary Materials Sourcing Players Market Share by Revenue in 2025
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 8. Local Sourcing Image
Figure 9. Central Sourcing Image
Figure 10. Others Image
Figure 11. Global Comparator Drug and Ancillary Materials Sourcing Sales by Type (2021 VS 2025 VS 2032) & (k units)
Figure 12. Global Comparator Drug and Ancillary Materials Sourcing Sales Market Share 2021 VS 2025 VS 2032
Figure 13. Global Comparator Drug and Ancillary Materials Sourcing Sales Market Share by Type (2021-2032)
Figure 14. Global Comparator Drug and Ancillary Materials Sourcing Revenue by Type (2021 VS 2025 VS 2032) & (k units)
Figure 15. Global Comparator Drug and Ancillary Materials Sourcing Revenue Market Share 2021 VS 2025 VS 2032
Figure 16. Global Comparator Drug and Ancillary Materials Sourcing Revenue Market Share by Type (2021-2032)
Figure 17. Drug Producers/Manufacturers Image
Figure 18. Academic and Research Institute Image
Figure 19. CMO Image
Figure 20. Others Image
Figure 21. Global Comparator Drug and Ancillary Materials Sourcing Sales by Application (2021 VS 2025 VS 2032) & (k units)
Figure 22. Global Comparator Drug and Ancillary Materials Sourcing Sales Market Share 2021 VS 2025 VS 2032
Figure 23. Global Comparator Drug and Ancillary Materials Sourcing Sales Market Share by Application (2021-2032)
Figure 24. Global Comparator Drug and Ancillary Materials Sourcing Revenue by Application (2021 VS 2025 VS 2032) & (k units)
Figure 25. Global Comparator Drug and Ancillary Materials Sourcing Revenue Market Share 2021 VS 2025 VS 2032
Figure 26. Global Comparator Drug and Ancillary Materials Sourcing Revenue Market Share by Application (2021-2032)
Figure 27. North America Comparator Drug and Ancillary Materials Sourcing Sales and Growth Rate (2021-2032) & (k units)
Figure 28. North America Comparator Drug and Ancillary Materials Sourcing Sales Market Share by Country (2021-2032)
Figure 29. U.S. Comparator Drug and Ancillary Materials Sourcing Sales and Growth Rate (2021-2032) & (k units)
Figure 30. Canada Comparator Drug and Ancillary Materials Sourcing Sales and Growth Rate (2021-2032) & (k units)
Figure 31. Mexico Comparator Drug and Ancillary Materials Sourcing Sales and Growth Rate (2021-2032) & (k units)
Figure 32. Europe Comparator Drug and Ancillary Materials Sourcing Sales and Growth Rate (2021-2032) & (k units)
Figure 33. Europe Comparator Drug and Ancillary Materials Sourcing Sales Market Share by Country (2021-2032)
Figure 34. Germany Comparator Drug and Ancillary Materials Sourcing Sales and Growth Rate (2021-2032) & (k units)
Figure 35. France Comparator Drug and Ancillary Materials Sourcing Sales and Growth Rate (2021-2032) & (k units)
Figure 36. U.K. Comparator Drug and Ancillary Materials Sourcing Sales and Growth Rate (2021-2032) & (k units)
Figure 37. Italy Comparator Drug and Ancillary Materials Sourcing Sales and Growth Rate (2021-2032) & (k units)
Figure 38. Netherlands Comparator Drug and Ancillary Materials Sourcing Sales and Growth Rate (2021-2032) & (k units)
Figure 39. Asia Pacific Comparator Drug and Ancillary Materials Sourcing Sales and Growth Rate (2021-2032) & (k units)
Figure 40. Asia Pacific Comparator Drug and Ancillary Materials Sourcing Sales Market Share by Country (2021-2032)
Figure 41. China Comparator Drug and Ancillary Materials Sourcing Sales and Growth Rate (2021-2032) & (k units)
Figure 42. Japan Comparator Drug and Ancillary Materials Sourcing Sales and Growth Rate (2021-2032) & (k units)
Figure 43. South Korea Comparator Drug and Ancillary Materials Sourcing Sales and Growth Rate (2021-2032) & (k units)
Figure 44. Southeast Asia Comparator Drug and Ancillary Materials Sourcing Sales and Growth Rate (2021-2032) & (k units)
Figure 45. India Comparator Drug and Ancillary Materials Sourcing Sales and Growth Rate (2021-2032) & (k units)
Figure 46. Australia Comparator Drug and Ancillary Materials Sourcing Sales and Growth Rate (2021-2032) & (k units)
Figure 47. South America, Middle East and Africa Comparator Drug and Ancillary Materials Sourcing Sales and Growth Rate (2021-2032) & (k units)
Figure 48. South America, Middle East and Africa Comparator Drug and Ancillary Materials Sourcing Sales Market Share by Country (2021-2032)
Figure 49. Brazil Comparator Drug and Ancillary Materials Sourcing Sales and Growth Rate (2021-2032) & (k units)
Figure 50. South Africa Comparator Drug and Ancillary Materials Sourcing Sales and Growth Rate (2021-2032) & (k units)
Figure 51. Saudi Arabia Comparator Drug and Ancillary Materials Sourcing Sales and Growth Rate (2021-2032) & (k units)
Figure 52. Turkey Comparator Drug and Ancillary Materials Sourcing Sales and Growth Rate (2021-2032) & (k units)
Figure 53. Argentina Comparator Drug and Ancillary Materials Sourcing Sales and Growth Rate (2021-2032) & (k units)
Figure 54. UAE Comparator Drug and Ancillary Materials Sourcing Sales and Growth Rate (2021-2032) & (k units)
Figure 55. Egypt Comparator Drug and Ancillary Materials Sourcing Sales and Growth Rate (2021-2032) & (k units)
Figure 56. Chile Comparator Drug and Ancillary Materials Sourcing Sales and Growth Rate (2021-2032) & (k units)
Figure 57. Global Comparator Drug and Ancillary Materials Sourcing Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 58. Global Comparator Drug and Ancillary Materials Sourcing Revenue Market Share by Region in Percentage: 2025 Versus 2032
Figure 59. North America Comparator Drug and Ancillary Materials Sourcing Revenue (2021-2032) & (US$ Million)
Figure 60. North America Comparator Drug and Ancillary Materials Sourcing Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 61. Europe Comparator Drug and Ancillary Materials Sourcing Revenue (2021-2032) & (US$ Million)
Figure 62. Europe Comparator Drug and Ancillary Materials Sourcing Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 63. Asia-Pacific Comparator Drug and Ancillary Materials Sourcing Revenue (2021-2032) & (US$ Million)
Figure 64. Asia-Pacific Comparator Drug and Ancillary Materials Sourcing Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 65. South America, Middle East and Africa Comparator Drug and Ancillary Materials Sourcing Revenue (2021-2032) & (US$ Million)
Figure 66. South America, Middle East and Africa Comparator Drug and Ancillary Materials Sourcing Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 67. Comparator Drug and Ancillary Materials Sourcing Value Chain
Figure 68. Manufacturing Cost Structure
Figure 69. Comparator Drug and Ancillary Materials Sourcing Production Mode & Process
Figure 70. Direct Comparison with Distribution Share
Figure 71. Distributors Profiles
Figure 72. Years Considered
Figure 73. Research Process
Figure 74. Key Executives Interviewed
Scope & coverage.
Types
- Local Sourcing
- Central Sourcing
- Others
Applications
- Drug Producers/Manufacturers
- Academic and Research Institute
- CMO
- Others
Companies covered
- Alliance Pharm
- Almac Group
- Catalent
- Cencora
- ClientPharma
- Clinical Services International (CSI)
- Clinigen
- Globyz Pharma
- Inceptua
- Mckesson Corporation
- Myonex
- NewLife Medicals
- Oximio
- Sharp Services, LLC
- Wuxi New Drug Development
- Thermo Fisher Scientific
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Comparator Drug and Ancillary Materials Sourcing Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Comparator Drug and Ancillary Materials Sourcing Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Comparator Drug and Ancillary Materials Sourcing Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Comparator Drug and Ancillary Materials Sourcing Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Comparator Drug and Ancillary Materials Sourcing Market Dynamics
- 2.1 Comparator Drug and Ancillary Materials Sourcing Industry Trends
- 2.2 Comparator Drug and Ancillary Materials Sourcing Industry Drivers
- 2.3 Comparator Drug and Ancillary Materials Sourcing Industry Opportunities and Challenges
- 2.4 Comparator Drug and Ancillary Materials Sourcing Industry Restraints
3 Comparator Drug and Ancillary Materials Sourcing Market by Manufacturers
- 3.1 Global Comparator Drug and Ancillary Materials Sourcing Revenue by Manufacturers (2021-2026)
- 3.2 Global Comparator Drug and Ancillary Materials Sourcing Sales by Manufacturers (2021-2026)
- 3.3 Global Comparator Drug and Ancillary Materials Sourcing Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Comparator Drug and Ancillary Materials Sourcing Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Comparator Drug and Ancillary Materials Sourcing Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Comparator Drug and Ancillary Materials Sourcing Manufacturers, Product Type & Application
- 3.7 Global Comparator Drug and Ancillary Materials Sourcing Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Comparator Drug and Ancillary Materials Sourcing Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Comparator Drug and Ancillary Materials Sourcing Players Market Share by Revenue in 2025
- 3.8.3 2025 Comparator Drug and Ancillary Materials Sourcing Tier 1, Tier 2, and Tier 3
4 Comparator Drug and Ancillary Materials Sourcing Market by Type
- 4.1 Comparator Drug and Ancillary Materials Sourcing Type Introduction
- 4.1.1 Local Sourcing
- 4.1.2 Central Sourcing
- 4.1.3 Others
- 4.2 Global Comparator Drug and Ancillary Materials Sourcing Sales by Type
- 4.2.1 Global Comparator Drug and Ancillary Materials Sourcing Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Comparator Drug and Ancillary Materials Sourcing Sales by Type (2021-2032)
- 4.2.3 Global Comparator Drug and Ancillary Materials Sourcing Sales Market Share by Type (2021-2032)
- 4.3 Global Comparator Drug and Ancillary Materials Sourcing Revenue by Type
- 4.3.1 Global Comparator Drug and Ancillary Materials Sourcing Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Comparator Drug and Ancillary Materials Sourcing Revenue by Type (2021-2032)
- 4.3.3 Global Comparator Drug and Ancillary Materials Sourcing Revenue Market Share by Type (2021-2032)
5 Comparator Drug and Ancillary Materials Sourcing Market by Application
- 5.1 Comparator Drug and Ancillary Materials Sourcing Application Introduction
- 5.1.1 Drug Producers/Manufacturers
- 5.1.2 Academic and Research Institute
- 5.1.3 CMO
- 5.1.4 Others
- 5.2 Global Comparator Drug and Ancillary Materials Sourcing Sales by Application
- 5.2.1 Global Comparator Drug and Ancillary Materials Sourcing Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Comparator Drug and Ancillary Materials Sourcing Sales by Application (2021-2032)
- 5.2.3 Global Comparator Drug and Ancillary Materials Sourcing Sales Market Share by Application (2021-2032)
- 5.3 Global Comparator Drug and Ancillary Materials Sourcing Revenue by Application
- 5.3.1 Global Comparator Drug and Ancillary Materials Sourcing Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Comparator Drug and Ancillary Materials Sourcing Revenue by Application (2021-2032)
- 5.3.3 Global Comparator Drug and Ancillary Materials Sourcing Revenue Market Share by Application (2021-2032)
6 Global Comparator Drug and Ancillary Materials Sourcing Sales by Region
- 6.1 Global Comparator Drug and Ancillary Materials Sourcing Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Comparator Drug and Ancillary Materials Sourcing Sales by Region (2021-2032)
- 6.2.1 Global Comparator Drug and Ancillary Materials Sourcing Sales by Region (2021-2026)
- 6.2.2 Global Comparator Drug and Ancillary Materials Sourcing Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Comparator Drug and Ancillary Materials Sourcing Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Comparator Drug and Ancillary Materials Sourcing Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Comparator Drug and Ancillary Materials Sourcing Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Comparator Drug and Ancillary Materials Sourcing Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Comparator Drug and Ancillary Materials Sourcing Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Comparator Drug and Ancillary Materials Sourcing Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Comparator Drug and Ancillary Materials Sourcing Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Comparator Drug and Ancillary Materials Sourcing Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Comparator Drug and Ancillary Materials Sourcing Revenue by Region
- 7.1 Global Comparator Drug and Ancillary Materials Sourcing Revenue by Region
- 7.1.1 Global Comparator Drug and Ancillary Materials Sourcing Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Comparator Drug and Ancillary Materials Sourcing Revenue by Region (2021-2026)
- 7.1.3 Global Comparator Drug and Ancillary Materials Sourcing Revenue by Region (2027-2032)
- 7.1.4 Global Comparator Drug and Ancillary Materials Sourcing Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Comparator Drug and Ancillary Materials Sourcing Revenue (2021-2032)
- 7.2.2 North America Comparator Drug and Ancillary Materials Sourcing Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Comparator Drug and Ancillary Materials Sourcing Revenue (2021-2032)
- 7.3.2 Europe Comparator Drug and Ancillary Materials Sourcing Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Comparator Drug and Ancillary Materials Sourcing Revenue (2021-2032)
- 7.4.2 Asia-Pacific Comparator Drug and Ancillary Materials Sourcing Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Comparator Drug and Ancillary Materials Sourcing Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Comparator Drug and Ancillary Materials Sourcing Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Alliance Pharm
- 8.1.1 Alliance Pharm Company Information
- 8.1.2 Alliance Pharm Business Overview
- 8.1.3 Alliance Pharm Comparator Drug and Ancillary Materials Sourcing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Alliance Pharm Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 8.1.5 Alliance Pharm Recent Developments
- 8.2 Almac Group
- 8.2.1 Almac Group Company Information
- 8.2.2 Almac Group Business Overview
- 8.2.3 Almac Group Comparator Drug and Ancillary Materials Sourcing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Almac Group Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 8.2.5 Almac Group Recent Developments
- 8.3 Catalent
- 8.3.1 Catalent Company Information
- 8.3.2 Catalent Business Overview
- 8.3.3 Catalent Comparator Drug and Ancillary Materials Sourcing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Catalent Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 8.3.5 Catalent Recent Developments
- 8.4 Cencora
- 8.4.1 Cencora Company Information
- 8.4.2 Cencora Business Overview
- 8.4.3 Cencora Comparator Drug and Ancillary Materials Sourcing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Cencora Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 8.4.5 Cencora Recent Developments
- 8.5 ClientPharma
- 8.5.1 ClientPharma Company Information
- 8.5.2 ClientPharma Business Overview
- 8.5.3 ClientPharma Comparator Drug and Ancillary Materials Sourcing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 ClientPharma Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 8.5.5 ClientPharma Recent Developments
- 8.6 Clinical Services International (CSI)
- 8.6.1 Clinical Services International (CSI) Company Information
- 8.6.2 Clinical Services International (CSI) Business Overview
- 8.6.3 Clinical Services International (CSI) Comparator Drug and Ancillary Materials Sourcing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Clinical Services International (CSI) Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 8.6.5 Clinical Services International (CSI) Recent Developments
- 8.7 Clinigen
- 8.7.1 Clinigen Company Information
- 8.7.2 Clinigen Business Overview
- 8.7.3 Clinigen Comparator Drug and Ancillary Materials Sourcing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Clinigen Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 8.7.5 Clinigen Recent Developments
- 8.8 Globyz Pharma
- 8.8.1 Globyz Pharma Company Information
- 8.8.2 Globyz Pharma Business Overview
- 8.8.3 Globyz Pharma Comparator Drug and Ancillary Materials Sourcing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Globyz Pharma Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 8.8.5 Globyz Pharma Recent Developments
- 8.9 Inceptua
- 8.9.1 Inceptua Company Information
- 8.9.2 Inceptua Business Overview
- 8.9.3 Inceptua Comparator Drug and Ancillary Materials Sourcing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Inceptua Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 8.9.5 Inceptua Recent Developments
- 8.10 Mckesson Corporation
- 8.10.1 Mckesson Corporation Company Information
- 8.10.2 Mckesson Corporation Business Overview
- 8.10.3 Mckesson Corporation Comparator Drug and Ancillary Materials Sourcing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Mckesson Corporation Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 8.10.5 Mckesson Corporation Recent Developments
- 8.11 Myonex
- 8.11.1 Myonex Company Information
- 8.11.2 Myonex Business Overview
- 8.11.3 Myonex Comparator Drug and Ancillary Materials Sourcing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Myonex Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 8.11.5 Myonex Recent Developments
- 8.12 NewLife Medicals
- 8.12.1 NewLife Medicals Company Information
- 8.12.2 NewLife Medicals Business Overview
- 8.12.3 NewLife Medicals Comparator Drug and Ancillary Materials Sourcing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 NewLife Medicals Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 8.12.5 NewLife Medicals Recent Developments
- 8.13 Oximio
- 8.13.1 Oximio Company Information
- 8.13.2 Oximio Business Overview
- 8.13.3 Oximio Comparator Drug and Ancillary Materials Sourcing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Oximio Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 8.13.5 Oximio Recent Developments
- 8.14 Sharp Services, LLC
- 8.14.1 Sharp Services, LLC Company Information
- 8.14.2 Sharp Services, LLC Business Overview
- 8.14.3 Sharp Services, LLC Comparator Drug and Ancillary Materials Sourcing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Sharp Services, LLC Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 8.14.5 Sharp Services, LLC Recent Developments
- 8.15 Wuxi New Drug Development
- 8.15.1 Wuxi New Drug Development Company Information
- 8.15.2 Wuxi New Drug Development Business Overview
- 8.15.3 Wuxi New Drug Development Comparator Drug and Ancillary Materials Sourcing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Wuxi New Drug Development Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 8.15.5 Wuxi New Drug Development Recent Developments
- 8.16 Thermo Fisher Scientific
- 8.16.1 Thermo Fisher Scientific Company Information
- 8.16.2 Thermo Fisher Scientific Business Overview
- 8.16.3 Thermo Fisher Scientific Comparator Drug and Ancillary Materials Sourcing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Thermo Fisher Scientific Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 8.16.5 Thermo Fisher Scientific Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Comparator Drug and Ancillary Materials Sourcing Value Chain Analysis
- 9.1.1 Comparator Drug and Ancillary Materials Sourcing Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Comparator Drug and Ancillary Materials Sourcing Production Mode & Process
- 9.2 Comparator Drug and Ancillary Materials Sourcing Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Comparator Drug and Ancillary Materials Sourcing Distributors
- 9.2.3 Comparator Drug and Ancillary Materials Sourcing Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$3,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst